No growth in revenue compared to H2 2021. Soaring expenses. Continued failure to execute on new products. Existing product runway facing imminent patent expiry. Incredibly overvalued.
No growth in revenue compared to H2 2021. Soaring expenses....
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.74 |
Change
-0.100(3.52%) |
Mkt cap ! $830.1M | |||
| Open | High | Low | Value | Volume |
| $2.83 | $2.85 | $2.74 | $1.384M | 500.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9000 | $2.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.75 | 3636 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.75 |
Change
-0.100 ( 3.55 %) |
||||
| Open | High | Low | Volume | ||
| $2.84 | $2.85 | $2.74 | 170141 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| NAN (ASX) Chart |